$2.3B
$45.5 Million
8.14% of portfolio
1,161,237
Q4 2024
Added 1.5%
$2.67B
$32.4 Million
5.78% of portfolio
425,000
Q4 2024
Added 6.25%
$5.64B
$31.6 Million
5.65% of portfolio
1,100,000
Q4 2024
Added 10.0%
$18.3B
$30.9 Million
5.51% of portfolio
1,400,000
Q3 2024
Reduced 3.45%
$4.24B
$30.7 Million
5.48% of portfolio
660,000
Q4 2024
Added 1.54%
$5.84B
$25.5 Million
4.55% of portfolio
82,500
Q4 2024
Reduced 17.5%
$1.92B
$23.5 Million
4.2% of portfolio
460,000
Q4 2024
Added 15.0%
$3.22B
$22.3 Million
3.99% of portfolio
285,000
Q4 2024
Reduced 15.56%
$918M
$18.6 Million
3.32% of portfolio
1,500,000
Q4 2024
Added 7.14%
$1.47B
$18.4 Million
3.28% of portfolio
1,095,924
Q4 2024
Added 13.5%
$809M
$18 Million
3.21% of portfolio
425,000
Q4 2024
Reduced 2.3%
$728M
$17.7 Million
3.17% of portfolio
940,083
Q4 2024
Added 9.26%
$2.16B
$16.4 Million
2.93% of portfolio
389,241
Q4 2024
Added 140.66%
$1.04B
$12.9 Million
2.3% of portfolio
279,445
Q4 2024
Reduced 3.79%
$942M
$12.1 Million
2.16% of portfolio
630,000
Q4 2024
Added 180.0%
$48.2M
$11 Million
1.97% of portfolio
3,972,318
Q4 2024
Added 40.75%
$157M
$10.6 Million
1.89% of portfolio
4,500,000
Q3 2024
Added 4.65%
$665M
$7.97 Million
1.42% of portfolio
2,250,000
Q4 2024
Added 50.0%
$166M
$7.71 Million
1.38% of portfolio
2,825,000
Q4 2024
New
$172M
$7.51 Million
1.34% of portfolio
1,575,000
Q4 2024
Reduced 7.35%
$363M
$7.26 Million
1.3% of portfolio
850,512
Q4 2024
Added 183.02%
$5.47B
$6.35 Million
1.13% of portfolio
75,000
Q4 2024
Reduced 6.25%
$167M
$6.27 Million
1.12% of portfolio
2,499,431
Q2 2024
New
$2B
$5.64 Million
1.01% of portfolio
300,000
Q4 2024
Reduced 7.69%
$5.17B
$5.49 Million
0.98% of portfolio
200,000
Q4 2024
Reduced 33.33%
$1.85B
$5.02 Million
0.9% of portfolio
130,000
Q4 2024
New
$1.37B
$3.48 Million
0.62% of portfolio
200,000
Q4 2024
New
$11B
$3.45 Million
0.62% of portfolio
50,000
Q3 2024
Reduced 60.0%
$387M
$3.21 Million
0.57% of portfolio
263,817
Q2 2024
Added 2.02%
$619M
$3.06 Million
0.55% of portfolio
159,614
Q4 2024
Reduced 69.6%
$1.75B
$2.93 Million
0.52% of portfolio
70,742
Q4 2024
Reduced 5.68%
$3.55B
$2.75 Million
0.49% of portfolio
100,000
Q4 2024
Reduced 55.56%
$59.4M
$2.12 Million
0.38% of portfolio
800,000
Q4 2024
Added 33.33%
$109M
$2.06 Million
0.37% of portfolio
500,000
Q4 2024
Reduced 66.67%
$4.33B
$2.05 Million
0.37% of portfolio
25,000
Q4 2024
Reduced 50.0%
$85.1M
$1.99 Million
0.36% of portfolio
800,000
Q4 2024
Added 23.08%
$21.6M
$1.77 Million
0.32% of portfolio
2,302,598
Q3 2024
Added 36.41%
$1.72B
$1.61 Million
0.29% of portfolio
40,000
Q4 2024
New
$2.76B
$1.6 Million
0.29% of portfolio
50,000
Q4 2024
New
$33.8M
$1.58 Million
0.28% of portfolio
1,000,000
Q4 2024
New
$4.27B
$1.28 Million
0.23% of portfolio
25,000
Q4 2024
Reduced 58.33%
$284M
$1.26 Million
0.23% of portfolio
410,586
Q4 2024
Reduced 41.34%
$73M
$1.2 Million
0.21% of portfolio
559,163
Q4 2024
New
$13.9M
$1.01 Million
0.18% of portfolio
1,015,340
Q4 2024
Reduced 23.15%
$962M
$252,000
0.05% of portfolio
9,992
Q4 2024
Reduced 92.01%
$49.5M
$131,000
0.02% of portfolio
100,000
Q4 2024
Reduced 42.31%
$528M
$98,000
0.02% of portfolio
9,958
Q4 2024
New
Mineralys Therapeutics Inc
-
$0
0.0% of portfolio
-
Q3 2024
Added 6.72%
-
$0
0.0% of portfolio
-
Q4 2024
Added 65.39%
Syros Pharmaceuticals Inc
-
$0
0.0% of portfolio
-
Q4 2024
New